MarketPR
CNXCConcentrix CNXC board adopts amended severance plan with 2x change-of-control payout and new standalone benefitJul 24QSIQSI in focus: Quantum-Si receives Nasdaq minimum bid price notice, faces January 19 compliance deadlineJul 24INSPInspire Medical Systems adds AtriCure CEO Michael Carrel to board in July 20 appointmentJul 24MARKETSCapital expenditure in focus as Alphabet raises the AI spending bar, three hyperscalers left to reportJul 24FJETFJET 8-K: Starfighters Space names CBIZ CPAs as auditor with STARLAUNCH program in Critical Design ReviewJul 24BVFLBVFL Q2 print: $0.42 per share, NIM at 4.58% as FHLB debt clearsJul 24MARKETSCAMJF declares JPY 55.0 semi-annual cash dividend, ex-date December 31Jul 24MSFTOpen-weight AI models in focus as Satya Nadella signals Microsoft's framework pushJul 24PROFPROF in focus: CAPTAIN trial data shows TULSA ablation outperforms robotic RP on penile length preservationJul 24$NEAR10-year Treasury yield stays near January 2025 high after Friday pullback puts $NEAR setup in focusJul 24CNXCConcentrix CNXC board adopts amended severance plan with 2x change-of-control payout and new standalone benefitJul 24QSIQSI in focus: Quantum-Si receives Nasdaq minimum bid price notice, faces January 19 compliance deadlineJul 24INSPInspire Medical Systems adds AtriCure CEO Michael Carrel to board in July 20 appointmentJul 24MARKETSCapital expenditure in focus as Alphabet raises the AI spending bar, three hyperscalers left to reportJul 24FJETFJET 8-K: Starfighters Space names CBIZ CPAs as auditor with STARLAUNCH program in Critical Design ReviewJul 24BVFLBVFL Q2 print: $0.42 per share, NIM at 4.58% as FHLB debt clearsJul 24MARKETSCAMJF declares JPY 55.0 semi-annual cash dividend, ex-date December 31Jul 24MSFTOpen-weight AI models in focus as Satya Nadella signals Microsoft's framework pushJul 24PROFPROF in focus: CAPTAIN trial data shows TULSA ablation outperforms robotic RP on penile length preservationJul 24$NEAR10-year Treasury yield stays near January 2025 high after Friday pullback puts $NEAR setup in focusJul 24
NewsMacro

BLUBF declares CAD 0.04 monthly cash dividend with August 31 ex-date

A monthly cash dividend of CAD 0.04 per share is in focus for BLUBF, with the ex-dividend date and record date both confirmed for August 31, 2026. Payment follows on September 15.

By Mateo FuentesMacro DeskJuly 25, 20262 min read
Share

A monthly cash dividend of CAD 0.04 per share is in focus for BLUBF, with the ex-dividend date and record date both confirmed for August 31, 2026. Payment follows on September 15.

The declared amount and eligibility

The dividend is denominated in Canadian dollars. At CAD 0.04 per share, the figure is fixed for this cycle, with no performance variable attached in the announcement. The ex-dividend and record dates fall on the same calendar day, August 31. That structure collapses the eligibility window to a single cutoff: shares must be held before that date, and ownership on the record date qualifies for the distribution.

Monthly cadence and what it means for the setup

BLUBF has designated the declared schedule as monthly. Frequency matters here. A monthly distribution cycle resets faster than a quarterly one, which means any change to the per-share amount surfaces earlier in the cadence. Income-focused holders get shorter gaps between payments. The September 15 payment closes this particular cycle. No forward guidance on subsequent per-share amounts appears in the current declaration.

What to watch

After September 15 settlement, the next item on the calendar is the following monthly declaration. No additional corporate actions were disclosed alongside this dividend. The record stands at CAD 0.04 for the current cycle.

About this story

Filed by the macro desk of MarketPR on July 25, 2026. Source: MarketPR newsroom. Indicative figures are not investment advice.

←Back to the news index

More from the Newsroom

All stories →
01Macro · CNXC

Concentrix CNXC board adopts amended severance plan with 2x change-of-control payout and new standalone benefit

In focus for CNXC holders: Concentrix Corporation's board adopted an Amended and Restated Executive Severance Plan on July 23, replacing the company's existing Change of Control Severance Plan. The revision raises the payout floor for executives terminated during a deal window an

Ines Ferreira2 min read
02Macro · QSI

QSI in focus: Quantum-Si receives Nasdaq minimum bid price notice, faces January 19 compliance deadline

Nasdaq's Listing Qualifications Department delivered a written deficiency notice to Quantum-Si Incorporated on July 23, 2026. The trigger: Class A common stock (QSI) had closed below $1.00 per share for 30 consecutive business days, breaching the minimum bid price requirement und

Lena Park2 min read
03Macro · INSP

Inspire Medical Systems adds AtriCure CEO Michael Carrel to board in July 20 appointment

A board seat at Inspire Medical Systems (NYSE: INSP) is in focus after the company's directors named Michael H. Carrel, the sitting president and chief executive of AtriCure, Inc. (NASDAQ: ATRC), as a Class III director on July 20, 2026. The 8-K hit the tape July 24. His term run

Mateo Fuentes2 min read